Interleukin 7 independent development of human B cells - PubMed (original) (raw)

Interleukin 7 independent development of human B cells

J A Prieyl et al. Proc Natl Acad Sci U S A. 1996.

Abstract

Mammalian hematopoietic stem cell (HSC) commitment and differentiation into lymphoid lineage cells proceed through a series of developmentally restricted progenitor compartments. A complete understanding of this process, and how it differs from HSC commitment and differentiation into cells of the myeloid/erythroid lineages, requires the development of model systems that support HSC commitment to the lymphoid lineages. We now describe a human bone marrow stromal cell culture that preferentially supports commitment and differentiation of human HSC to CD19+ B-lineage cells. Fluorescence activated cell sorterpurified CD34++/lineage-cells were isolated from fetal bone marrow and cultured on human fetal bone marrow stromal cells in serum-free conditions containing no exogenous cytokines. Over a period of 3 weeks, CD34++/lineage- cells underwent commitment, differentiation, and expansion into the B lineage. Progressive changes included: loss of CD34, acquisition of and graded increases in the level of cell surface CD19, and appearance of immature B cells expressing mu/kappa or mu/lambda cell surface Ig receptors. The tempo and phenotype of B-cell development was not influenced by the addition of IL-7 (10 ng/ml), or by the addition of goat anti-IL-7 neutralizing antibody. These results indicate a profound difference between mouse and human in the requirement for IL-7 in normal B-cell development, and provide an experimental system to identify and characterize human bone marrow stromal cell-derived molecules crucial for human B lymphopoiesis.

PubMed Disclaimer

Similar articles

• Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
  Uckun FM, Haissig S, Ledbetter JA, Fidler P, Myers DE, Kuebelbeck V, Weisdorf D, Gajl-Peczalska K, Kersey JH, Ramsay NK. Uckun FM, et al. Blood. 1992 Jun 15;79(12):3369-79. Blood. 1992. PMID: 1375851
• In vitro reconstitution of human B-cell ontogeny: from CD34(+) multipotent progenitors to Ig-secreting cells.
  Fluckiger AC, Sanz E, Garcia-Lloret M, Su T, Hao QL, Kato R, Quan S, de la Hera A, Crooks GM, Witte ON, Rawlings DJ. Fluckiger AC, et al. Blood. 1998 Dec 15;92(12):4509-20. Blood. 1998. PMID: 9845515
• Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells.
  Johnson SE, Shah N, Panoskaltsis-Mortari A, LeBien TW. Johnson SE, et al. J Immunol. 2005 Dec 1;175(11):7325-31. doi: 10.4049/jimmunol.175.11.7325. J Immunol. 2005. PMID: 16301638
• Fidelity and infidelity in commitment to B-lymphocyte lineage development.
  Rolink AG, Schaniel C, Busslinger M, Nutt SL, Melchers F. Rolink AG, et al. Immunol Rev. 2000 Jun;175:104-11. Immunol Rev. 2000. PMID: 10933595 Review.
• In vitro studies of human B lymphopoiesis.
  Pribyl JR, Dittel BN, LeBien TW. Pribyl JR, et al. Ann N Y Acad Sci. 1995 Sep 29;764:9-18. doi: 10.1111/j.1749-6632.1995.tb55799.x. Ann N Y Acad Sci. 1995. PMID: 7486595 Review. No abstract available.

Cited by

• IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion.
  Kaiser FMP, Janowska I, Menafra R, de Gier M, Korzhenevich J, Pico-Knijnenburg I, Khatri I, Schulz A, Kuijpers TW, Lankester AC, Konstantinidis L, Erlacher M, Kloet S, van Schouwenburg PA, Rizzi M, van der Burg M. Kaiser FMP, et al. Blood. 2023 Sep 28;142(13):1113-1130. doi: 10.1182/blood.2023019721. Blood. 2023. PMID: 37369082 Free PMC article.
• In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation.
  Bozhilov YK, Hsu I, Brown EJ, Wilkinson AC. Bozhilov YK, et al. Cells. 2023 Mar 14;12(6):896. doi: 10.3390/cells12060896. Cells. 2023. PMID: 36980237 Free PMC article. Review.
• An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.
  Geron I, Savino AM, Fishman H, Tal N, Brown J, Turati VA, James C, Sarno J, Hameiri-Grossman M, Lee YN, Rein A, Maniriho H, Birger Y, Zemlyansky A, Muler I, Davis KL, Marcu-Malina V, Mattson N, Parnas O, Wagener R, Fischer U, Barata JT, Jamieson CHM, Müschen M, Chen CW, Borkhardt A, Kirsch IR, Nagler A, Enver T, Izraeli S. Geron I, et al. Nat Commun. 2022 Feb 3;13(1):659. doi: 10.1038/s41467-022-28218-7. Nat Commun. 2022. PMID: 35115489 Free PMC article.
• Ikaros-Associated Diseases: From Mice to Humans and Back Again.
  Boast B, Nunes-Santos CJ, Kuehn HS, Rosenzweig SD. Boast B, et al. Front Pediatr. 2021 Jul 16;9:705497. doi: 10.3389/fped.2021.705497. eCollection 2021. Front Pediatr. 2021. PMID: 34354970 Free PMC article. Review.
• Regulation of Energy Metabolism during Early B Lymphocyte Development.
  Urbanczyk S, Stein M, Schuh W, Jäck HM, Mougiakakos D, Mielenz D. Urbanczyk S, et al. Int J Mol Sci. 2018 Jul 27;19(8):2192. doi: 10.3390/ijms19082192. Int J Mol Sci. 2018. PMID: 30060475 Free PMC article. Review.

References

1. 1. Blood. 1995 Apr 15;85(8):2038-44 - PubMed
2. 1. J Exp Med. 1995 Apr 1;181(4):1519-26 - PubMed
3. 1. Nature. 1995 Sep 7;377(6544):65-8 - PubMed
4. 1. J Exp Med. 1995 Oct 1;182(4):973-82 - PubMed
5. 1. Immunity. 1995 Oct;3(4):459-73 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program